Medicinal Product Shortages - update - 10 January 2024

Notice type: Advisory

Date: 10/01/2024

This is the HPRA’s latest weekly update on medicines shortages. We publish this information each week to keep patients and healthcare professionals informed of current and resolved shortages.

We recognise that medicine shortages can be challenging for those who rely on medicines for their health and well-being. It is the case that for many medicines supplied in Ireland, there is more than one strength, form, pack size or brand available from different suppliers.

Your doctor or pharmacist will often be able to supply an alternative strength, form or product to ensure continuity of treatment if the medicine you have been taking is unavailable.

 

Resolved shortages

The following shortages have been resolved and supply has resumed to the Irish market:

Product

Active Ingredient(s)

Aripiprazole Teva 5mg Tablets

PA1986/019/001

Teva B.V.

Aripiprazole

Aripiprazole Teva 10mg Tablets

PA1986/019/002

Teva B.V.

Aripiprazole

Aripiprazole Teva 15mg Tablets

PA1986/019/003

Teva B.V.

Aripiprazole

Co-Amoxiclav TEVA 1000mg/200mg Powder for Solution for Injection/infusion

PA0749/011/002

Teva Pharma B.V.

Amoxicillin and clavulanic acid

Creon 25000 Gastro Resistant Capsules

PA23355/006/002

Viatris Healthcare Limited

Pancreas powder

Doxorubicin Teva 2mg/ml Concentrate for Solution for Infusion

(25ml presentation)

PA0749/083/001

Teva Pharma B.V.

Doxorubicin

ELIGARD 22.5mg Powder and Solvent for Solution for Injection

PA0812/005/002

Recordati Industria Chimica e Farmaceutica SpA

Leuprorelin acetate

Eumovate Cream 0.05% w/w

PA1077/006/001

GlaxoSmithKline (Ireland) Limited

Clobetasone

Ezetimibe/Simvastatin Teva Pharma 10mg/20mg Tablets

PA1986/067/001

Teva B.V.

Ezetimibe & simvastatin

Gelaspan Solution for Infusion

PA0736/034/001

B. Braun Melsungen AG

Various

Genotropin MiniQuick 0.4mg Powder and Solvent for Solution for Injection

PA0822/128/004

Pfizer Healthcare Ireland

Somatropin

Germentin 500mg/125mg Film Coated Tablets

PA0577/034/001

McDermott Laboratories Ltd., T/A Gerard Laboratories

Amoxicillin & clavulanic acid

Leucovorin-Teva 10mg/ml Concentrate for Solution for Infusion

(30ml presentation)

PA0749/001/001

Teva Pharma B.V.

Folinic acid

Salamol Steri-Neb 2.5mg/2.5ml Nebuliser Solution

PA1986/086/001

Teva B.V.

Salbutamol

Tevaquel XL 50mg Prolonged Release Tablets

PA0749/060/006

Teva Pharma B.V.

Quetiapine

Tostran 2% Gel

PA2288/001/004

Kyowa Kirin Holdings B.V.

Testosterone

 

Newly notified shortages

The HPRA has been notified of a shortage of the following products:

Product

Active Ingredient(s)

Atenomel 25mg Tablets

PA0126/069/003

Clonmel Healthcare Ltd

Atenolol

Atenomel 100mg Tablets

PA0126/069/002

Clonmel Healthcare Ltd

Atenolol

Amlodipine Viatris 10mg Tablets

PA23266/002/002

Viatris Limited

Amlodipine

Chlorphenamine 10mg/ml Solution for Injection

PA2262/003/001

Evolan Pharma AB

Chlorphenamine

Epilim Syrup 200mg/5ml Oral Solution

PA0540/150/015

Sanofi-Aventis Ireland Limited T/A SANOFI

Sodium valproate

Ibuprofen B. Braun 400mg Solution for Infusion

PA0736/041/001

B. Braun Melsungen AG

Ibuprofen

Klacid Forte 500mg Film Coated Tablets

PA23355/013/002

Viatris Healthcare Limited

Clarithromycin

Rosuvastatin Viatris 20mg Tablets

PA23266/003/003

Viatris Limited

Rosuvastatin

Valsartan Teva 160mg Film Coated Tablets

PA0749/084/003

Teva Pharma B.V.

Valsartan

Valsartan Viatris 40mg Film Coated Tablets

PA23266/006/001

Viatris Limited

Valsartan

Please see the shortages section of the HPRA website for further information

The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.

 



« Back